Loading

Immuto Scientific

June 05, 2024
Company Presentation
Platform for Therapeutics
Company Presentation Theater 4
Immuto Scientific is a platform biotech company pioneering a new era in therapeutic discovery by targeting the once thought 'undruggable' proteins and pathways, bringing hope to millions of patients facing conditions with no cure. Our innovative platform combines cutting-edge technology with deep scientific expertise to unlock novel therapies that traditional methods couldn't reach. The heart of our approach is a powerful structure-based drug discovery engine that enables high throughput characterization of protein structures in live cells to identify novel drug targets that are highly disease-specific protein conformations. With our leading-edge platforms, we develop best-in-class therapeutics with exceptional safety and efficacy profiles. We have a preclinical internal pipeline of oncology assets and we partner with companies in multiple different disease areas.
Immuto Scientific
Company Website: http://www.immutotherapeutics.com
Lead Product in Development: ADC for AML
Number Of Unlicensed Products (For Which You Are Seeking Partners): 3

Company HQ City

Madison

Company HQ State

WI

Company HQ Country

United States

CEO/Top Company Official

Faraz Choudhury, PhD

Development Phase of Primary Product

Pre-Clinical
Speakers
Faraz Choudhury, PhD
CEO
Immuto Scientific
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS